ResMed (NYSE: RMD) has outperformed the market over the past 10 years by 2.9% on an annualized basis producing an average annual return of 16.12%. Currently, ResMed has a market capitalization of ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a ...

I want scale, innovation, and long-term demand. This company delivers all three. The post If I could only buy and hold a single ASX stock, this would be it appeared first on The Motley Fool Australia.

Women’s sleep apnea symptoms differ from men’s and can often be confused with hormonal shifts. Researchers are working to ...

Consistency and compounding are often the real drivers of wealth. The post The $10-a-day ASX share investing habit that could ...

The state doled out approximately $10 million in tax incentives for projects in Johnson County communities within the last ...

How many of these top picks do you own? The post In Wilsons Advisory's ideal portfolio, what are the 10 top stock picks?

Byron Kaye is the Reuters chief companies correspondent for Australia, based in Sydney. Over 10 years at Reuters he has covered banks, retail, healthcare, media, technology and politics, among other ...

Quality, resilience, and structural tailwinds matter most for me over 10 years. The post Why I'd buy and hold these 5 ASX 200 shares until 2036 appeared first on The Motley Fool Australia.

INDIANA – Governor Mike Braun and the Indiana Economic Development Corporation are celebrating a February of major ...

Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non-small cell lung cancer (NSCLC) and Parkinson's disease using ivonescimab, a novel immunotherapy currently ...

Australia Equity Fund portfolio returned 2.06% over the quarter on a net asset value basis, lagging the ASX 200's 7.33% ...